Drug Shortage Report for THALLOUS CHLORIDE TI 201 INJECTION

Last updated on 2020-09-21 History
Report ID 124539
Drug Identification Number Not Applicable/non applicable
Brand name THALLOUS CHLORIDE TI 201 INJECTION
Common or Proper name Thallous Chloride TI 201
Company Name GE HEALTHCARE CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) THALLIUM CHLORIDE
Strength(s) 37MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 8.8 mL
ATC code V09GX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-15
Estimated end date 2020-09-20
Actual end date 2020-09-20
Shortage status Resolved
Updated date 2020-09-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-09-18 English Compare
v2 2020-09-18 French Compare
v3 2020-09-21 English Compare
v4 2020-09-21 French Compare

Showing 1 to 4 of 4